Catalyst Wire Dossier Catalyst Wire Dossier

Wild-Type Reovirus

reovirus
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Wild-Type Reovirus, covering 2024-05-17 to 2024-05-17. Get the full timeline:

Most recent: Clinical Trial Update: Wild-Type Reovirus in Combination With Carfilzomib and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 1]

See pricing